Dr. Jessica Shepherd: On Menopause, HRT, and Longevity Tips for Women | TUH #253

Dr. Shepherd explains the concept of a 'good, better, best' window for HT. The WHI study used older women, many smokers, with pre-existing heart disease, leading to the false conclusion that HT increased cardiovascular risk. When started in the perimenopausal transition, estrogen exerts anti-inflammatory effects, maintains insulin sensitivity, and protects the brain, bones, and gut. She emphasizes that the goal is to 'capture women before they hit menopause to give them the best building blocks' so they remain optimized in their 60s, 70s, and 80s rather than experiencing a catastrophic decline. The recent FDA removal of the black box warning reinforces this timing strategy.

Dr. Shepherd emphasizes that muscle is 'metabolic currency' and a non-negotiable for female longevity. After menopause, the loss of estrogen compounds the natural age-related decline in muscle mass (sarcopenia), leading to frailty, insulin resistance, and increased risk of falls and fractures. Resistance training counteracts this by maintaining or increasing muscle mass, which acts as a glucose sponge, improves insulin sensitivity, and strengthens bones through mechanical load. She rejects the cultural notion that women should only use light weights, insisting that the body adapts to heavier loads and that building muscle does not make women bulky but instead functional and resilient. Even a brief, focused 30-minute session is sufficient if done consistently.

Dr. Shepherd dispels the common misconception that creatine is a bodybuilder-only supplement or that it harms the kidneys. She clarifies that creatine is an amino acid compound that helps regenerate ATP, the cellular energy currency, thereby improving muscle performance and recovery. Recent data show it also supports brain energy metabolism, which is particularly relevant for women experiencing brain fog during perimenopause and menopause. She recommends starting at 2g to gauge tolerance, then increasing to 5g, and notes that for brain health, studies suggest up to 10g may be more effective. She frames creatine as a foundational supplement that helps the body 'where it needs help.'

Dr. Shepherd links mind-body medicine directly to autoimmune disease management. She explains that the body is a vehicle for the mind, and chronic stress, unprocessed trauma, and emotional burden create a state of internal inflammation that can manifest as autoimmune conditions. By incorporating mindfulness, individuals can lower their stress response, improve immune regulation, and potentially slow disease progression. She cites Dr. Gabor Mate's work on trauma and disease. Even a short daily practice of 10 minutes can create significant shifts. She pairs this with saying 'hello to the sun' as a way to connect with nature and get morning light, which supports circadian rhythm.

Dr. Shepherd explains that a single fasting glucose is just a snapshot, while a hemoglobin A1c gives a 3-month average, but a CGM shows the dynamic patterns—how a meal, a walk, or a cold plunge affects glucose in real time. This empowers users to make immediate changes, such as pairing carbohydrates with protein or walking after meals. She shares an anecdote of seeing her own glucose drop after a cold plunge, demonstrating the power of hormetic stressors. She also points out that ethnic differences in glucose metabolism (e.g., rice) can be visualized with CGM, making it a tool for truly personalized nutrition.

Dr. Shepherd acknowledges the limitation of standard labs: they measure what's in the blood at one moment, but perimenopause is characterized by erratic fluctuations. She recommends a broad panel to rule out other issues like hypothyroidism or low vitamin D, which can produce similar symptoms. The DUTCH test is useful for tracking how hormones are being metabolized and for understanding adrenal function. She emphasizes that labs are a 'starting ground for a conversation,' not a definitive diagnosis. The key is to combine objective data with the patient's subjective experience.

Dr. Shepherd connects diet directly to gut health, noting that the gut has estrogen receptors and that declining estrogen increases gut permeability ('leaky gut'). A high-fiber, whole foods diet supports a healthy microbiome and reduces systemic inflammation. She stresses protein's role in maintaining muscle and brain health, and criticizes the lack of education on adequate protein intake for women. She often has patients keep a 2-week food log without judgment to identify pro-inflammatory patterns. Morning protein helps lower cortisol and prevents blood sugar spikes that can set off a cascade of cravings and energy crashes.

In her practice, she saw women presenting with complex conditions that were treated surgically or with medication, but she felt something was missing. She realized that the healthcare system is designed to fix 'train wrecks' but rarely addresses the foundational lifestyle factors that lead to disease. This led her to seek out training in root-cause analysis, emphasizing nutrition, stress management, and emotional health. She now combines her surgical skill with proactive lifestyle medicine, aiming to prevent women from needing surgery or managing chronic disease.

She explains that perimenopause is a process lasting years, where estrogen and progesterone fluctuate unpredictably, causing symptoms long before periods stop. Because the receptors for these hormones are widespread—in the brain, muscle, skin, gut—the symptoms can be diverse and severe. Labs provide a snapshot, but the body is experiencing a dynamic decline. She emphasizes that listening to the patient's narrative is more important than the lab printout, and that this empathetic approach is a missing piece in modern medicine. By validating women's experiences, clinicians can intervene earlier with hormone therapy or lifestyle adjustments.

Dr. Shepherd explains that the study's participants were not the ideal candidates for starting hormone therapy—experts now recommend beginning in the perimenopausal transition or early menopause (45–55) to maximize benefits and minimize risks. The black box warning caused a 70-80% reduction in HT use, leaving millions of women to endure severe menopausal symptoms and lose the long-term protective effects of estrogen on bone, brain, and heart. The reversal opens the door for a new conversation, but many doctors and patients remain uninformed or fearful. She emphasizes the need to educate both physicians and the public about the real risk-benefit profile.

Her book 'Generation M' (released in 2024) covers sex, muscle, brain, meditation, and hormones, but it's not solely about hormone therapy—it's a framework for lifestyle pillars. She describes it as a love letter to her patients and friends, filled with relatable stories. By calling it a 'comedic love story,' she aims to reduce the fear and isolation many feel. She also created the Modern Meno community to provide ongoing support, webinars, and peer connection, recognizing that women thrive when they share experiences.